MEDiThings was featured in a healthcare CEO interview highlighting the company’s vision to create a new patient-centered paradigm for bladder dysfunction care.
The article introduced neurogenic bladder as a condition caused by neurological disorders such as spinal cord injury, diabetes, or stroke. Patients with neurogenic bladder may have difficulty recognizing the need to urinate and often need to empty the bladder regularly through catheterization. If not properly managed, the condition can lead to complications such as urinary tract infections and kidney damage.
According to the article, Aram Kim, CEO of MEDiThings and a urologist specializing in neurogenic bladder, recognized the seriousness of bladder dysfunction through patients he met in clinical practice. After opening Korea’s first neurogenic bladder clinic within a university hospital, he saw firsthand how existing treatment guidelines often fail to reflect the real-life challenges faced by patients.
MEDiThings is developing a wearable bladder monitoring solution designed to support patients who need better awareness of their bladder status in daily life. The device is worn on the lower abdomen and works with a smartphone application to help patients, families, and caregivers monitor bladder-related information and receive timely alerts.
The article also noted that current bladder monitoring methods often rely on large ultrasound devices that are mainly used in hospital settings by trained healthcare professionals. As a wearable solution, MEDiThings’ approach aims to improve accessibility and convenience for patients outside the hospital.
The solution may also help reduce the burden of manually recording voiding diaries. By enabling more structured monitoring of urination timing, voided volume, and residual urine-related information, MEDiThings’ technology has the potential to support both patients and clinicians in managing conditions such as neurogenic bladder, overactive bladder, and nocturia.
The article highlighted MEDiThings’ broader ambition to improve the standard of care for bladder dysfunction. Aram Kim emphasized that the company aims to move beyond the limitations of existing guidelines and lead a new medical care paradigm centered on the real needs of patients.
MEDiThings is continuing to advance its technology and clinical development efforts, with the goal of helping patients, families, caregivers, and healthcare professionals manage bladder care more accurately, conveniently, and with greater confidence.
[Published: May 26, 2023]
Source: https://www.medigatenews.com/news/2720019608
MEDiThings was featured in a healthcare CEO interview highlighting the company’s vision to create a new patient-centered paradigm for bladder dysfunction care.
The article introduced neurogenic bladder as a condition caused by neurological disorders such as spinal cord injury, diabetes, or stroke. Patients with neurogenic bladder may have difficulty recognizing the need to urinate and often need to empty the bladder regularly through catheterization. If not properly managed, the condition can lead to complications such as urinary tract infections and kidney damage.
According to the article, Aram Kim, CEO of MEDiThings and a urologist specializing in neurogenic bladder, recognized the seriousness of bladder dysfunction through patients he met in clinical practice. After opening Korea’s first neurogenic bladder clinic within a university hospital, he saw firsthand how existing treatment guidelines often fail to reflect the real-life challenges faced by patients.
MEDiThings is developing a wearable bladder monitoring solution designed to support patients who need better awareness of their bladder status in daily life. The device is worn on the lower abdomen and works with a smartphone application to help patients, families, and caregivers monitor bladder-related information and receive timely alerts.
The article also noted that current bladder monitoring methods often rely on large ultrasound devices that are mainly used in hospital settings by trained healthcare professionals. As a wearable solution, MEDiThings’ approach aims to improve accessibility and convenience for patients outside the hospital.
The solution may also help reduce the burden of manually recording voiding diaries. By enabling more structured monitoring of urination timing, voided volume, and residual urine-related information, MEDiThings’ technology has the potential to support both patients and clinicians in managing conditions such as neurogenic bladder, overactive bladder, and nocturia.
The article highlighted MEDiThings’ broader ambition to improve the standard of care for bladder dysfunction. Aram Kim emphasized that the company aims to move beyond the limitations of existing guidelines and lead a new medical care paradigm centered on the real needs of patients.
MEDiThings is continuing to advance its technology and clinical development efforts, with the goal of helping patients, families, caregivers, and healthcare professionals manage bladder care more accurately, conveniently, and with greater confidence.
[Published: May 26, 2023]
Source: https://www.medigatenews.com/news/2720019608